Mylan introduces generic Xeloda tablets
The company secured final approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for the product, which is indicated as monotherapy,
Voro Therapeutics and Alloy Therapeutics have formed a strategic research partnership to develop tumour-selective, next-generation masked T-cell engager (TCE) therapeutics.
Data Highlights BIOD-531 was associated with superior glucose control compared to Humalog Mix 75/25 throughout the day of observation. BIOD-531 was also associated with superior glucose control compared
The administration of particulate matter, if present in an intravenous drug, poses a potential safety risk to patients such as a thromboembolism or a life-threatening pulmonary embolism. Other
Conducted on 15 healthy volunteers at Linear Clinical Research’s facility in Perth, Australia, the study validated additional pharmacokinetic parameters associated with the safety and elimination profile that remained
The retinal device will be offered to late-stage retinitis pigmentosa (RP) patients in six German university clinics and teaching hospitals. Retina Implant CEO Walter-G Wrobel said: "Since receiving